Trial NCT04355728
Publication Lanzoni G, Stem Cells Transl Me, 2020
Primary outcome on the report: Safety, as defined by the occurrence of pre-specified infusion associated AEs, occurring within 6 hours from each infusion; Cardiac arrest or death within 24 h post infusion; Incidence of AEs

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.